Sign in to NCBI

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA521712 ID: 521712

ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin (human)

See Genome Information for Homo sapiens
Navigate Across
66644 additional projects are related by organism.
We explored the regulation of alternative splicing in a cell model of breast cancer resistance to doxorubicin, and the impact of the depletion of two splicing factors (ZRANB2 and SYF2) in this context. More...
AccessionPRJNA521712; GEO: GSE126365
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsTanaka I et al., "ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.", Nucleic Acids Res, 2020 Mar 18;48(5):2676-2693
SubmissionRegistration date: 11-Feb-2019
[CNRS/ENS Lyon/UCBL/HCL] Laboratoire de Biologie Moléculaire de la Cellule UMR5239
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments18
Publications
PubMed1
PMC1
Other datasets
BioSample18
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes9207
SRA Data Details
ParameterValue
Data volume, Gbases408
Data volume, Tbytes0.22

Supplemental Content

Related information

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI
Support Center